Showing Results for: “type 1 diabetes”

Get expert clinical perspectives on diabetes-related amputations and regulatory opportunities. Join the Clinical Advisory Working Group (CAWG) today.

The American Diabetes Association (ADA) strongly supports the re-introduction of legislation to expand access to Diabetes Self-Management Training (DSMT) for Medicare beneficiaries. The ADA thanks House Diabetes Caucus Co-Chairs Congressman Tom Reed (R-NY) and Congresswoman Diana DeGette (D-CO), and Vice Chairs Congresswoman Suzan DelBene (D-WA), Congresswoman Susan Brooks (R-IN), Congressman Raul Ruiz (D-CA), and Congressman Mike Kelly (R-PA) for their leadership in introducing the Expanding Access to Diabetes Self-Management Training Act in the U.S. House of Representatives. DSMT is an

Symposium Will Feature Research on Genomic Analysis and Glucose Monitoring Technologies Today, findings from two studies funded by the ADA Pathway to Stop Diabetes ® research program highlight innovative science and the latest diabetes developments on genomic profiling and glucose control. The symposium, 2022 Pathway to Stop Diabetes, will be presented at the 82nd Scientific Sessions held by the American Diabetes Association ® (ADA) in New Orleans, LA. Genomic Profiling & Type 2 Diabetes The symposium will highlight findings from a new study, Deciphering Longitudinal Cell Type-Specific Defects

Researchers from the University of North Carolina and Northwestern University Medical School win prestigious Pathway to Stop Diabetes grants to advance diabetes research Today, the American Diabetes Association ® (ADA) announced the two winners of the Pathway to Stop Diabetes ® (Pathway) grants, a five-year grant to support breakthroughs in translational science, clinical science, technology, care, and potential cures in the field of diabetes. The first grant recipient is Anna Kahkoska, MD, PhD, an assistant professor at the Department of Nutrition in the Gillings School of Global Public

The American Diabetes Association (ADA) is awarding this year’s prestigious  Pathway to Stop Diabetes grants, totaling $3.25 million dollars, to two promising researchers. Both will receive $1.625 million dollars over a five-year grant term to support breakthroughs in basic science, clinical science, technology, care and potential cures in the field of diabetes. Judith Agudo, PhD , Dana-Farber Cancer Institute in Boston, Massachusetts, receives a Pathway Accelerator Award for her research project titled “Harnessing immune privilege mechanisms from stem cells to protect beta-cells from immune

In recent years, diabetes technology has evolved at a rapid pace, and the use of insulin pumps and continuous glucose monitoring (CGM) systems has grown tremendously. To foster a more active role in diabetes management among youth, professionals encourage consistent utilization of monitoring tools across multiple environments. A professional interest group presentation entitled “Diabetes Technology Use in Schools, Camps, and Emergency Rooms,” focused on the use of diabetes technology for children and adolescents in a variety of settings, today at the American Diabetes Association’s® (ADA’s)

CEO Tracey D. Brown Pushes for Federal Action to Make Insulin and Other Diabetes Medications and Supplies More Affordable The American Diabetes Association® today urged immediate federal action to bring down the skyrocketing price of diabetes care before the House Energy and Commerce Committee. In a statement for the congressional record submitted in conjunction with a Health Subcommittee hearing on ways for Congress to make prescription drugs more affordable, ADA CEO Tracey D. Brown spoke to the unique financial challenges faced by Americans with diabetes and stressed the need for immediate